Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
Memorial Sloan Kettering Cancer Center
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Beni-Suef University
Institut Claudius Regaud
M.D. Anderson Cancer Center
University of Kansas Medical Center
Hoosier Cancer Research Network
M.D. Anderson Cancer Center
University of California, San Francisco
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Columbia University
M.D. Anderson Cancer Center
New York Medical College
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Charles Drew University of Medicine and Science
Instituto do Cancer do Estado de São Paulo
Institute of Cancer Research, United Kingdom
Memorial Sloan Kettering Cancer Center
University of Nebraska
University Hospital Tuebingen
Ankara City Hospital Bilkent
Institut Claudius Regaud
University of Alabama at Birmingham
Thomas Jefferson University
University of Washington
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
University Hospital, Bordeaux
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
Stanford University
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Wake Forest University Health Sciences